InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,012.80
(
-1.16%
)
US TECH 100
16,801.60
(
-1.52%
)
Dow Jones
37,866.82
(
-1.54%
)
Brent Oil
86.83
(
-0.45%
)
Bitcoin
64,110.00
(
-0.27%
)
Post# of 251596
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

zipjet

Send PM Follow Ignore
Followers 36
Posts 2619
Boards Moderated 0
Alias Born 10/06/2003

zipjet

Re: DewDiligence post# 211480

Friday, 05/26/2017 9:23:33 AM

Friday, May 26, 2017 9:23:33 AM

Post# of 251596
>>The PML patient had been on Tysabri until April, so Ocrevus is probably not the culprit.

One of the recurring themes is that PML shows up in patients that have been on multiple treatments.

More significant risk for Ocrevus is the 1:200 risk of breast cancer.

It is astonishing what foolish things one can temporarily believe if one thinks too long alone ... where it is often impossible to bring one's ideas to a conclusive test either formal or experimental. J.M. Keynes

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up